Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
11,218,564
-
Share change
-
+24,499
-
Total reported value
-
$111,066,000
-
Price per share
-
$9.89
-
Number of holders
-
43
-
Value change
-
+$196,114
-
Number of buys
-
9
-
Number of sells
-
10
Institutional Holders of MOONLAKE IMMUNOTHERAPEUTICS - COM (HLXA) as of Q3 2021
As of 30 Sep 2021 MOONLAKE IMMUNOTHERAPEUTICS - COM (HLXA) had 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 11,218,564 shares of stock of the company.
Largest 10 holders included ADAGE CAPITAL PARTNERS GP, L.L.C., PRICE T ROWE ASSOCIATES INC /MD/, RTW INVESTMENTS, LP, BlackRock Inc., RA CAPITAL MANAGEMENT, L.P., CITADEL ADVISORS LLC, STALEY CAPITAL ADVISERS INC, Ghost Tree Capital, LLC, WELLINGTON MANAGEMENT GROUP LLP, and Cormorant Asset Management, LP.
This table shows 43 institutional shareholders of the security as of 30 Sep 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.